2nd Qatar Diabetes and Obesity Research Symposium

​2nd Qatar Diabetes and Obesity Research Symposium

(Thursday, 2 March 2023, from 7:30 am to 1:30 pm)
At Sheraton Grand Doha Resort and Convention Center

Hybrid program

7.30 - 8.00am

Registration and Coffee

8.00 - 8.05am

Welcome Address

Prof. Shahrad Taheri,
Chair of the Diabetes Research Sub-Committee,
National Diabetes Strategy

8.05 - 8.10am

Opening Remarks

Dr. Sheikh Mohamed Al -Thani,
Director of Public Health, MoPH

Session 1


Dr. Ammira Al-Shabeeb Akil
Principal Investigator and the Head of Precision Medicine of Diabetes,
Obesity and Cancer research program, Sidra Medicine

Dr. Mohammed H. Jarrar
Senior Scientific Expert, Qatar Research, Development and Innovation (QRDI)

8.10 - 8.50am

The metabolic impact of Ramadan fasting

Prof. Ahmed S. BaHammam,
Professor of Medicine, University Sleep Disorders Center, King Saud University

8.50 - 9.10am

Precision health in prevention of type 2 diabetes. Update on advances to counter insulin resistance

Prof. Paul Thornalley,
Scientific Director, Diabetes Research Center, Qatar Biomedical Research Institute (QBRI) Hamad Bin Khalifa University (HBKU)

9.10 - 9.30am

GATA-3 as a potential therapeutic target for reversing insulin resistance

Dr. Mohamed Elrayess,
Director of Basic Research, Vice President for Health and Medical Sciences Office, Qatar University (QU)

9.30 - 9.50am

Epidemiology of Diabetes in Qatar and Projection up to 2050

Prof. Laith Abu-Raddad,
Professor of Population Health Sciences, Weill Cornell Medicine-Qatar (WCM-Q)

9.50 - 10.30am

Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation

Prof. Carel le Roux,
Director of Metabolic Medicine Group, University College Dublin

10.30 - 11.00am

Coffee Break - Networking

Session 2


Dr. Nahla Afifi, Director, Qatar Biobank (QBB), Qatar Foundation (QF)

Prof. Abdul- Badi Abou-Samra, Co-Chair National Diabetes Committee (MoPH) and Director of Qatar Metabolic Institute (QMI)

11.00 - 11.20am

Association of low plasma salivary a-amylase activity with increased Inflammation and Cardiometabolic Risk in a high- risk cohort of Qatari individuals with overweight/ obesity

Dr. Abdelilah Arredouani, Scientist, Diabetes Research Center, Qatar Biomedical Research Institute (QBRI), Assistant Professor, College of Health & Life Sciences, Hamad Bin Khalifa University (HBKU)

11.20 - 11.40am

The role of precision health in the prevision and management of diabetes

Dr. David Brown,
Science and Programmes Director, Qatar Precision Medicine Institute (QPMI), Qatar Foundation (QF)

11.40am - 12.00pm

Pray time 

12:00 - 12.20pm

A Multiomics View of Diabetes

Dr. Karsten Suhre,
Director of the Bioinformatics Core and Professor of Physiology and Biophysics, Weill Cornell Medical College (WCM-Q)

12.20 - 1.00pm

Diabetes No More! Remission of type 2 diabetes in the DiRECT and STANDby trials

Prof. Michael Lean,Professor of Human Nutrition, University of Glasgow

1.00 - 1.30pm

Discussion - Reflections - Roadmap going forward

Prof. Shahrad Taheri


End of Symposium